New hope for Tough-to-Treat lung cancer: testing a novel drug combo

NCT ID NCT07325136

Summary

This study is testing a new drug called BMS-986525, both by itself and combined with an existing immunotherapy drug (nivolumab), for people with small cell lung cancer that has come back or stopped responding to standard chemotherapy. The main goals are to see if the treatments are safe and what side effects they cause, and to get an early look at whether they can shrink tumors. The study will enroll about 240 people whose cancer has progressed after at least one prior platinum-based chemotherapy regimen.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • Local Institution - 0001

    NOT_YET_RECRUITING

    Rozzano, Milano, 20089, Italy

    Contact

  • Local Institution - 0003

    NOT_YET_RECRUITING

    Craiova, 200347, Romania

    Contact

  • Local Institution - 0005

    NOT_YET_RECRUITING

    Durham, North Carolina, 27710, United States

    Contact

  • Local Institution - 0009

    NOT_YET_RECRUITING

    Madrid, 28041, Spain

    Contact

  • Local Institution - 0011

    NOT_YET_RECRUITING

    Detroit, Michigan, 48201, United States

    Contact

  • Local Institution - 0018

    NOT_YET_RECRUITING

    Chuo-ku, Tokyo, 104-0045, Japan

    Contact

  • Local Institution - 0020

    NOT_YET_RECRUITING

    Hirakata, Osaka, 573-1191, Japan

    Contact

  • Local Institution - 0023

    NOT_YET_RECRUITING

    Timișoara, Timiș County, 300239, Romania

    Contact

  • Local Institution - 0026

    NOT_YET_RECRUITING

    Buffalo, New York, 14263, United States

    Contact

  • SCRI Oncology Partners

    RECRUITING

    Nashville, Tennessee, 37203, United States

    Contact Phone: •••-•••-••••

  • University Hospitals Cleveland Medical Center

    RECRUITING

    Cleveland, Ohio, 44106, United States

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.